
|

| |
Track this member and follow
their portfolio moves with tickerspy™ alerts |
 |
|
keithsimpson
Portfolio List (1): |
Stem Cells
|
| |
Performance |
|
|
|
Ideas |
|
|
|
Community |
|
| |
Today:
Week:
1-month:
All-time:
|
0.0%
+3.8%
+11.4%
+81.3%
|
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
|
-1.0%
+1.6%
+4.0%
+29.0%
|
|
|
|
|
|
|
|
|
Share this portfolio on Facebook
Share this portfolio on Twitter
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
| |
|
| |

Click
a column to sort | Scroll over columns for more information |
|
|
| ASTM |
$0.57 |
-0.02 |
-3.4% |
177,156 |
61% |
$24.9M |
- |
10% |
-77% |
-76.2% |
No Alerts/News
|
|
|
| CUR |
$1.49 |
+0.04 |
+2.8% |
2,133,474 |
507% |
$102.5M |
- |
255% |
-24% |
-14.4% |
1 Alert (0 News) - View
|
|
|
| CYTX |
$2.63 |
-0.02 |
-0.8% |
268,628 |
115% |
$176.6M |
- |
31% |
-47% |
-57.4% |
new: Oxford Club Recommendation
added 12/15/09
1 Alert (0 News) - View
|
|
|
| GERN |
$1.12 |
-0.03 |
-2.6% |
930,253 |
141% |
$146.0M |
- |
23% |
-63% |
-80.4% |
No Alerts/News
|
|
|
| KOOL |
$0.91 |
+0.03 |
+3.3% |
617 |
4% |
$15.0M |
- |
49% |
-36% |
-60.8% |
No Alerts/News
|
|
|
| NBS |
$0.59 |
0.00 |
-0.1% |
681,611 |
47% |
$100.4M |
- |
74% |
-30% |
-64.2% |
1 Alert (0 News) - View
|
|
|
| OPXA |
$1.67 |
-0.07 |
-4.0% |
168,247 |
79% |
$13.3M |
- |
56% |
-68% |
-13.0% |
No Alerts/News
|
|
|
| OSIR |
$11.27 |
+0.67 |
+6.3% |
175,051 |
163% |
$371.1M |
- |
129% |
-22% |
+61.0% |
1 Alert (0 News) - View
|
|
|
| PSTI |
$3.05 |
0.00 |
0.0% |
116,712 |
88% |
$178.9M |
- |
35% |
-39% |
+185.0% |
No Alerts/News
|
|
|
| STEM |
$1.93 |
+0.06 |
+3.2% |
517,740 |
159% |
$75.0M |
- |
227% |
-28% |
-84.9% |
1 Alert (0 News) - View
|
|
|
|
|
Discuss this portfolio with keithsimpson
|
|
|
|
| |

|
| |
|
| |

|
| |
ThermoGenesis Reports Third Quarter Fiscal 2013 Results KOOL
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 14, 04:13PM from (globenewswire.com) RANCHO CORDOVA, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling
Flag
Post a comment
Cytori Reports First Quarter 2013 Business and Financial Results CYTX
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 09, 04:01PM from (www.businesswire.com) Cytori Therapeutics (NASDAQ: CYTX) today reports its first quarter 2013 financial results and provides updates on clinical
Flag
Post a comment
ThermoGenesis Announces Registration Approval of AXP in China KOOL
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 04:13PM from (globenewswire.com) RANCHO CORDOVA, Calif., May 8, 2013 (GLOBE NEWSWIRE) -- ThermoGenesis Corp. (Nasdaq:KOOL), a leading supplier of enabling
Flag
Post a comment
Osiris Therapeutics Announces First Quarter 2013 Financial Results OSIR
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - May 07, 08:00AM from (www.businesswire.com) Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat
Flag
Post a comment
Aastrom to Host First Quarter 2013 Investor Call on May 8, 2013 ASTM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 03, 04:13PM from (globenewswire.com) ANN ARBOR, Mich., May 3, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific,
Flag
Post a comment
Osiris Therapeutics Announces First Quarter 2013 Financial Results Conference Call OSIR
Linked by BusinessWire ( track newsfeed | ignore newsfeed ) - April 25, 05:00PM from (www.businesswire.com) Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced that it will report its financial results for the first quarter
Flag
Post a comment
Aastrom to Hold Annual Meeting of Shareholders on May 2, 2013 ASTM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 25, 04:43PM from (globenewswire.com) ANN ARBOR, Mich., April 25, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific
Flag
Post a comment
Aastrom Biosciences Announces First Patients Treated in ixCELL-DCM Clinical Study of ixmyelocel-T ASTM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 19, 09:13AM from (globenewswire.com) ANN ARBOR, Mich., April 19, 2013 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), the leading developer of patient-specific
Flag
Post a comment
Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine PSTI
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 18, 03:13AM from (globenewswire.com) HAIFA, Israel, April 18, 2013 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer
Flag
Post a comment
StemCells, Inc. to Participate at 2013 Regen Med Investor Day in New York STEM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 15, 09:13AM from (globenewswire.com) NEWARK, Calif., April 15, 2013 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that President and CEO Martin
Flag
Post a comment
CORRECTION -- StemCells, Inc. Closes $10 Million Debt Financing STEM
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - April 09, 04:43PM from (globenewswire.com) NEWARK, Calif., April 9, 2013 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by StemCells,
Flag
Post a comment
|
|